Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
AIMS/HYPOTHESIS: An excess cancer incidence of 20-25% has been identified among persons with diabetes, most of whom have type 2 diabetes. We aimed to describe the association between type 1 diabetes and cancer incidence. METHODS: Persons with type 1 diabetes were identified from five nationwide diabetes registers: Australia (2000-2008), Denmark (1995-2014), Finland (1972-2012), Scotland (1995-2012) and Sweden (1987-2012). Linkage to national cancer registries provided the numbers of incident cancers in people with type 1 diabetes and in the general population. We used Poisson models with adjustment for age and date of follow up to estimate hazard ratios for total and site-specific cancers. RESULTS: A total of 9,149 cancers occurred among persons with type 1 diabetes in 3.9 million person-years. The median age at cancer diagnosis was 51.1 years (interquartile range 43.5-59.5). The hazard ratios (HRs) (95% CIs) associated with type 1 diabetes for all cancers combined were 1.01 (0.98, 1.04) among men and 1.07 (1.04, 1.10) among women. HRs were increased for cancer of the stomach (men, HR 1.23 [1.04, 1.46]; women, HR 1.78 [1.49, 2.13]), liver (men, HR 2.00 [1.67, 2.40]; women, HR 1.55 [1.14, 2.10]), pancreas (men, HR 1.53 [1.30, 1.79]; women, HR 1.25 [1.02,1.53]), endometrium (HR 1.42 [1.27, 1.58]) and kidney (men, HR 1.30 [1.12, 1.49]; women, HR 1.47 [1.23, 1.77]). Reduced HRs were found for cancer of the prostate (HR 0.56 [0.51, 0.61]) and breast (HR 0.90 [0.85, 0.94]). HRs declined with increasing diabetes duration. CONCLUSION: Type 1 diabetes was associated with differences in the risk of several common cancers; the strength of these associations varied with the duration of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Variably increased risk has been reported for cancers of the breast (postmenopausal) endometrium ovary gall bladder, stomach and esophagus, kidney, thyroid (papillary, follicular, and anaplastic but not medullary), colon, bladder, and pancreas.1733,1734,1739–1752”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1746]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219 · cited 1×
“HR estimates for site-specific cancers were highest for cancer types in which obesity is an established risk factor, namely stomach, colorectal, kidney, endometrial and pancreatic cancers [21].”
BackgroundWorldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
Pellegriti, G., Frasca, F., Regalbuto, C., Squatrito, S., & Vigneri, R. (2013) · Journal of Cancer Epidemiology · doi:10.1155/2013/965212 · Cited by 1,288 · cited 1×
“The worldwide incidence rates of thyroid cancer have increased steeply in recent decades [30, 31], partly due to enhanced detection through the use of more sensitive diagnostic equipment.”
BackgroundType-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105 · cited 1×
“For example, it is well established that pancreatic cancer can induce diabetes [35].”
BackgroundVigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
Diabetes mellitus and risk of breast cancer: A meta‐analysis
Larsson, S. C., Mantzoros, C. S., & Wolk, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22717 · Cited by 875 · cited 1×
“Previous studies assessing the influence of type 2 or unspecified diabetes on breast cancer have displayed a similar or elevated risk compared with the general population, although these findings are largely limited to post-menopausal women [28].”
ResultType 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E., & Ioannidis, J. P. A. (2015) · BMJ · doi:10.1136/bmj.g7607 · Cited by 860
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782 · cited 1×
“were previously shown to lead to an increased risk of prostate cancer [33], while hyperglycaemia has also been shown to”
BackgroundWideroff, L., Gridley, G., Chow, W. H., Linet, M., Mellemkjaer, L., Olsen, J. H., Keehn, S., & Borch-Johnsen, K. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.18.1360 · Cited by 627 · cited 1×
“Although this definition of type 1 diabetes is not strictly comparable with ours, the result is consistent with our findings [19].”
Result
Research works printed but not linked: 1
- Harrell JFE Regression modeling strategies 2006 New York Springer
Cited by
Items 101–200 of 202
Feodoroff, M., Harjutsalo, V., Mäkimattila, S., & Groop, P. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.100884 · Cited by 10
Diabetes and pancreatic cancer risk in a multiracial cohort
Conway, R. B. N., Hudson, A., Munro, H. M., Fu, Z., McClain, D. A., & Blot, W. J. (2023) · Diabetic Medicine · doi:10.1111/dme.15234 · Cited by 9
“A study by Carstensen et al. 30 describing the association between cancer incidence and type 1 diabetes found a smaller excess risk among persons with type 1 diabetes than had been previously observed for type 2 diabetes, suggesting that insulin therapy does not contribute to elevated diabetes risk among people with d…”
BackgroundChatterjee, A., Roy, T., & Swarnakar, S. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111435 · Cited by 9
Fávaro, R. R., Prieto, D. M. M., Herrmann, J., Sonnemann, J., Schleußner, E., Markert, U. R., & Zorn, T. M. T. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05940-5 · Cited by 9
Watso, J. C., Robinson, A. T., Singar, S., Cuba, J. N., & Koutnik, A. P. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00694.2023 · Cited by 8
Diabetes: an Overview for Clinical Oncologists
Lee, Y.-N., & Chowdhury, T. A. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.03.012 · Cited by 8
Fredriksson, M., Persson, E., Dahlquist, G. G., Möllsten, A., & Lind, T. (2021) · Diabetic Medicine · doi:10.1111/dme.14771 · Cited by 8
Chen, J., Huang, J., Yang, Z., Tang, K., Wu, C., Ye, H., Shi, J., & Zhu, Y. (2026) · Nano-Micro Letters · doi:10.1007/s40820-026-02169-w · Cited by 7
“In particular, diabetes elevates the risk of cancer incidence (ca. 20% ~ 25% higher than non-diabetic individuals [3]) and worsens the prognosis of various cancers such as breast, liver, colorectal, and melanoma malignancies [4–7].”
Insulin and Insulin-Like Growth Factor-1 Associated Cancers
Dey, S. K., & Senapati, S. (2021) · Springer eBooks · doi:10.1007/978-981-16-1846-8_3 · Cited by 7
Hu, J., Feng, Y., Li, B., Wang, F., Qian, Q., Tian, W., Niu, L., & Wang, X. (2023) · PeerJ · doi:10.7717/peerj.15948 · Cited by 6
Tao, L. V., Karasinska, J. M., Souza, V. G. P., Loree, J. M., Johnson, J. D., Renouf, D. J., & Schaeffer, D. F. (2026) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2025.1645459 · Cited by 6
Ke-xun, Y., & Wang, Q. (2021) · International Urology and Nephrology · doi:10.1007/s11255-021-02911-w · Cited by 6
Sund, R., & Gissler, M. (2022) · Springer eBooks · doi:10.1007/978-1-4614-6625-3_5-1 · Cited by 6
Self-citationDiabetes mellitus and the female reproductive system tumors
Sharafutdinova, K. I., Shlyapina, V. S., Baeva, A. I., Timurshin, A. A., Sabanaeva, I. E., Nakieva, A. G., Kalashnikova, M. F., & Khabibov, M. (2023) · Problems of Endocrinology · doi:10.14341/probl13282 · Cited by 6
Getu, M. A., Zhang, X., Ying, Y., & Gong, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-89288-3 · Cited by 5
“The reduced risk of malignant melanoma among individuals with T1D aligns with findings from other large T1D cohorts 5 .”
Dragun, M., Filipović, N., Racetin, A., Kostić, S., & Vukojević, K. (2021) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000937 · Cited by 5
Zhao, J., Li, W., Chen, L., Li, M., & Deng, W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1407329 · Cited by 5
Thuesen, A. C. B., & Vaag, A. A. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13238 · Cited by 5
“However, a pooled analysis of register data from Danish, Australian, Finnish, Scottish and Swedish patients, interestingly, showed a similar temporal relationship between diagnosis of type 1 diabetes and cancer.(14) In summary, these studies show that duration of diabetes is inversely associated with incidence of canc…”
BackgroundCo-Managing Patients with Type 1 Diabetes and Cancer
Best, C. J., Thosani, S., Ortiz, M. R., Levesque, C. A., Varghese, S. S., & Lavis, V. R. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0766-y · Cited by 6
Wouters, R., Vankerckhoven, A., Verreet, W., Ceusters, J., & Coosemans, A. (2022) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2022-003570 · Cited by 5
The Link Between Diabetes and Cancer: Converging Mechanistic and Epidemiologic Evidence
Lipscombe, L. L., Ali, S., & Lega, I. C. (2026) · Diabetes · doi:10.2337/dbi26-0003 · Cited by 4
Hong, J. W. (2023) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2023.5.e9 · Cited by 4
Shin, S., Kim, M. H., Oh, C., Ha, E., & Ryoo, J. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3848 · Cited by 4
“Although prior studies have reported an increased cancer risk with prolonged T1D duration, they have not specifically addressed the elevated cancer risk among older age groups [13, 16].”
Tan, W., Zhang, J., Deng, Z., Dai, F., Tang, L., Hu, W., & Liu, H. (2023) · Cancer Medicine · doi:10.1002/cam4.6073 · Cited by 4
Romanová, A., Malinovská, J., Lustigová, M., Urbanová, J., Brunerová, L., Vejtasová, V., Verma, A., Duong, T. A., Šťovíček, J., & Brož, J. (2022) · Vnitřní lékařství · doi:10.36290/vnl.2022.022 · Cited by 4
Sex-specific transcriptome similarity networks elucidate comorbidity relationships
Sánchez-Valle, J., Flores-Rodero, M., Costa, F. X., Carbonell‐Caballero, J., Núñez‐Carpintero, I., Tabarés-Seisdedos, R., Rocha, L. M., Cirillo, D., & Valencia, A. (2025) · Communications Medicine · doi:10.1038/s43856-025-01329-0 · Cited by 3
Glucose-induced RYBP suppresses tumor cell aerobic glycolysis and migration
Chen, X., 刘维佳, Li, T., Xia, W., & Chen, D. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150089 · Cited by 3
Li, W., Ke, D., Xu, Y., Wang, Y., Wang, Q., Tan, J., Wu, H., & Cheng, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1464421 · Cited by 3
Chen, Z., Wang, Y., Zhao, D., Lin, Y., & He, L. T. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-024-00015-2 · Cited by 2
“A growing number of epidemiological studies have revealed that diabetes mellitus increases the risk of most common malignant tumors, including pancreas, endo-metrium, liver, breast, lung, bladder, and colorectal cancer [14–19].”
Diabetes and tumor risk: a 23-year Danish national cohort study
Skovbjerg, K. F., Antvorskov, J. C., Stokholm, L., Bille, T. D., Andersen, N., Andresen, J. L., Bek, T., Hajar, J., Kawasaki, R., Laugesen, C. S., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1725065 · Cited by 2
Genome Instability and Somatic Mutagenesis in Autoimmune Diseases
Vijayraghavan, S., & Saini, N. (2026) · Cancers · doi:10.3390/cancers18030513 · Cited by 2
“…risk for cancer development, studies aimed at finding the link between T1D and cancer risk have largely yielded mixed results, with marginally elevated risk for gastrointestinal https://doi.org/10.3390/cancers18030513 and pancreatic cancer, and lowered risk for breast and prostate cancers [95,96].”
InfluentialAbbes, A., Boudemia, R., & Rechreche, H. (2023) · Journal of Applied Biological Sciences · doi:10.71336/jabs.1090 · Cited by 2
“…two populations, mentioning for example obesity, insulin treatment or diabetes-specific metabolic failures such as hyperglycemia, may provide an alternative explanation for the excessive risk of certain cancers among diabetic patients, considering that these failures are common in both types [35].”
Hong, J. W. (2023) · Journal of Korean Diabetes · doi:10.4093/jkd.2023.24.1.12 · Cited by 2
Mäkimattila, S., Harjutsalo, V., Feodoroff, M., & Groop, P. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae054 · Cited by 2
“Likewise, higher risk only in women was seen in a large 5-country combined T1D register with data from Australia, Denmark, Finland, Scotland, and Sweden [16].”
BackgroundUsefulness of Practitioner-Led Pancreatic Cancer Screening
Matsumoto, K., Kushiyama, Y., Izumi, A., Ohnishi, K., Miura, M., Ohuchi, Y., Hori, I., Nakamura, T., Hori, K., Koshino, K., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12092257 · Cited by 2
The odds of neoplasia in dogs with and without diabetes mellitus
Manoharan, S. A., & Hess, R. S. (2022) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16370 · Cited by 1
Huang, Y., Li, J., Liu, J., Xu, Y., Mo, F., Su, J., & Tao, R. (2023) · Community Dental Health · doi:10.1922/cdh_00025huang09 · Cited by 1
“…of persons with T1DM (Australia, Denmark, Finland, Scotland, and Sweden) found that those with type 1 diabetes had a higher incidence of cancer of the liver, pancreas, kidney, endometrium, and ovary and a lower incidence of prostate cancer than the general population (Carstensen et al. , 2016).”
Badrick, E., Gallagher, E. J., & Renehan, A. G. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch60 · Cited by 1
Role of metabolic syndrome and lifestyle factors in endometrial cancer risk and prevention
Kwiatkowska, A., Małek, N., Emerla, S., Brożyna, A., Bydliński, A., Karłowicz, K., Hermanowska, M., Lubomirska, J., Figurowska, P., & Ciulkiewicz, Ł. (2024) · Quality in Sport · doi:10.12775/qs.2024.32.55862 · Cited by 1
Chen, K., Wang, G., Hu, J., Zhou, Y., & Ma, H. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i2.98423 · Cited by 1
Yan, B., Fritsche, A., Haußner, E., Inamdar, T. V., Laumen, H., Boettcher, M., Gericke, M. T., Michl, P., & Rosendahl, J. (2025) · Cancers · doi:10.3390/cancers17101676 · Cited by 1
“Interestingly, recent studies have revealed that type 1 diabetes patients also exhibit modestly elevated hazard ratios for pancreatic cancer, with men showing a slightly higher risk than women [163].”
Kolongolo, S. S., Swaya, T. O., Kutolo, E., & Guyah, B. (2025) · Acta Cytologica · doi:10.1159/000547062 · Cited by 1
“Comparably the current study showed a high prevalence of cytomorphological abnormalities among diabetes mellitus women consistent with other studies [3, 15].”
Zhang, Y., Zhang, J., Li, H., Zhuang, Y., You, Q., Su, Y., Zheng, X., & Li, S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1422881 · Cited by 1
Ghadirzadeh, B., Assadi, S., Moradveisi, B., & Moradi, Y. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-02041-8 · Cited by 1
“…Union and Australia was entered twice for regional analyses, once in each geographic stratum, so that regional estimates would not be conflated [39]; similarly, six studies that included both population-based and hospital-based samples were duplicated within the setting subgroup so that each…”
Swolin‐Eide, D., Lyckå, A. P., Forsander, G., Novák, D., Grillari, J., Diendorfer, A. B., Hackl, M. J., & Magnusson, P. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343117 · Cited by 1
“Well-powered studies have confirmed the link between cancer and cancer-related mortality in T1D, supporting further investigation of miRNAs as biomarkers and therapeutic targets [31,32].”
Early glycaemic exposure and cancer risk in people with newly diagnosed type 2 diabetes
Zhang, X., Yang, A., Wu, H., Lau, E. S. H., Shi, M., Fan, B., Chow, E., Kong, A. P. S., Chan, J. C. N., Ronald, C. W., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06758-7 · Cited by 1
“However, hyperglycaemia itself is implicated, as evidenced by the elevated cancer risk in type 1 diabetes [22, 23], which is less associated with insulin resistance.”
Coexistence of Type-1 Diabetes Mellitus and Papillary Thyroid Carcinoma
Çalapkulu, M., Sencar, M. E., Düğer, H., Bayram, S. M., Ünsal, İ. Ö., Çakal, E., & Özbek, M. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666191104114551 · Cited by 1
Ist Krebs bei Kids diabetischer Mütter häufiger?
Stupin, J. H. (2020) · Info Diabetologie · doi:10.1007/s15034-020-0638-z · Cited by 1
¿Podría ser la diabetes factor de riesgo para cáncer de pene?: a propósito de un caso
Diaz-Meyzan, L., & Diaz-Lazo, A. V. (2021) · REVISTA PERUANA DE CIENCIAS DE LA SALUD · doi:10.37711/rpcs.2021.3.1.265 · Cited by 1
The diabetes mellitus and oncopathоlogy
Zhuravlyova, L., & Сокольникова, Н. В. (2021) · Medicine of Ukraine · doi:10.37987/1997-9894.2021.2(248).229022 · Cited by 1
Diabetes and cancer: Epidemiologic and physiopathogenic links
Gourine, M., & Chentouf, A. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.4181959 · Cited by 1
Vigneri, R., & Sciacca, L. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_12 · Cited by 1
Çalapkulu, M., Sencar, M. E., Sakız, D., Ünsal, İ. Ö., Tekinyıldız, M., Düğer, H., Özbek, M., & Çakal, E. (2023) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-023-01268-3 · Cited by 1
“A few studies have investigated the relationship between T1DM and thyroid cancer, and their results are controversial [33–35].”
InfluentialHASSAN, M., Mn, A., IDREES, M., Akram, I., Aijaz, A., Malik, F. N., & SADDIQA, A. (2023) · Biological and Clinical Sciences Research Journal · doi:10.54112/bcsrj.v2023i1.564 · Cited by 1
Determining the Role of miR-133a in the Diabetic Heart
Kambis, T. N. (2022) · DigitalCommons@UNMC · Cited by 1
Implications for the Mother with Diabetes
Wender-Ożegowska, E., & Sacks, D. A. (2017) · Wiley eBooks · doi:10.1002/9781119043805.ch27
Nervo, A., Fracchia, A. C., Ragni, A., D’Angelo, V., Arvat, E., & Gallo, M. (2020) · Journal of Public Health · doi:10.1007/s10389-020-01200-7
Diabetes, metformin and gastric adenocarcinoma
Zheng, J. (2021) · Figshare
The Link between Cancer, Autoimmunity and DiabetesPreprint
Petrić, D. (2021) · doi:10.14293/s2199-1006.1.sor-.ppxal5b.v1
Vigneri, R., & Sciacca, L. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_12-1
Vigneri, R., & Sciacca, L. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_12-2
Vigneri, R., & Sciacca, L. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_12 · Cited by 1
Typ-1-Diabetes – besondere Herausforderungen für Frauen
Schäfer-Graf, U. M., & Seifert‐Klauss, V. (2022) · Der Diabetologe · doi:10.1007/s11428-022-00857-w
Explorando el vínculo clínico-epidemiológico entre el cáncer y la diabetes mellitus tipo 2
Díaz, C. I. E., Carrasco, A. P. M., Proaño, C. A. V., Jara, D. A. S., Verduga, D. J. S., & Aveiga, R. A. R. (2019) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.4165886
Clinical History and Risk Factors of Pancreatic Cancer
Hüser, N., Aßfalg, V., & Frieß, H. (2023) · Wiley eBooks · doi:10.1002/9781119876007.ch127
Cancer in diabetes: Who is who?
García‐Jiménez, C., García-Martínez, J. M., & Chocarro‐Calvo, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-88426-6.00003-8
Sarkar, A., Dhar, S., Bera, S., Chakravarti, M., Verma, A., Khan, M. A., Prasad, P., Das, J., Choudhury, P. R., Sultana, J., et al. (2026) · The Journal of Immunology · doi:10.1101/2024.04.04.588206
“A retrospective study by Carstensen et al., 2016 of 9000 cancer patients with T1D spanning 5 countries suggested a reduced risk of melanoma, breast carcinoma or prostate cancer, but an increased risk for patients developing colon, esophageal, liver or stomach cancer.”
BackgroundHansen, K., Peters, K., Burkert, C. K., Brose, E., Calvisi, D. F., Ehricke, K., Engeler, M., Knuth, E., Kröger, N., Löhr, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111438
“However, some studies also show an increased risk in diabetes mellitus type I [18–20].”
BackgroundPhoseka, S., Jaya, Z. N., & Thembane, N. (2025) · Student s Journal of Health Research Africa · doi:10.51168/sjhrafrica.v6i3.1493
Pankreas Kanserinin Değiştirilebilir Risk Faktörleri: Karsinomun Kralından Kaçınılabilir mi
Aydoğan, Ç., & Yılmaz, H. (2025) · Istanbul Yeni Yuzyil Universitesi Yeni Yuzyil Journal of Medical Sciences · doi:10.46629/jms.2025.174
Pathway Evaluation of Symptoms Until Diagnosis in a Cohort of Pediatric Oncology Patients
Tavares, C. F., Costa, I. S., Almeida, S., Jerónimo, M., & Brito, M. J. (2025) · Pediatric Oncall · doi:10.7199/ped.oncall.2026.41
Fukui, T., Kobayashi, T., Awata, T., Ikegami, H., Imagawa, A., Oikawa, Y., Osawa, H., Kawasaki, E., Kuwabara, M., Kobayashi, K., et al. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005229
Bennett, H. O., Bogumil, D. D., Kysh, L., van den Brandt, P. A., Watanabe, R. M., Siegmund, K. D., & Cortessis, V. K. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112976
Seeh, D. O. (2023) · DigitalGeorgetown (Georgetown University Library)
The use of beta blockers, aspirin, and the risk of mortality in patients with prostate cancer
Assayag, J. (2016) · eScholarship@McGill (McGill) · doi:10.82308/11310
Hirsz, M. (2021) · Research Commons (University of Waikato)
Kohil, A. (2021) · Qatar University QSpace (Qatar University)
The Effect of Anti-Diabetic Drugs on the Metabolism of Papillary Thyroid Cancer
Castanho, M. S. (2025) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Cardiovascular diseases and malignant neoplasms — what do they have in common?
Shlyk, I. F., Kechkina, V. D., & Besedina, D. Y. (2025) · Medical Herald of the South of Russia · doi:10.21886/2219-8075-2025-16-4-55-61
Insulin Recepto Loss Impairs Mammary Tumourigenesis in Mice
Podmore, L. (2023) · TSpace (University of Toronto)
Joentausta, R. M. (2024) · Tampere University Institutional Repository (Tampere University)
Zádori, N. (2023) · Pesci Egyetemi Archivum (University of Pécs)
Cheang, N., Chen, X., Zhang, H., Su, Q., & Du, S. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s581946
Ruze, R., Tuerxun, R., Jiang, T., Aji, Y. S. A. T., & Aji, T. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014946
Understanding the link between diabetes and cancer
Morris, D. (2026) · Independent Nurse · doi:10.12968/indn.2026.3.14
Diabetes and colorectal cancer : epidemiological and physiopathological studies
Mroueh, F. M. (2017) · theses.fr (ABES) · doi:10.70675/65c64643z9facz43ddz8889z715719c5dcb8
Predicting stress-induced vulnerability to depression in diabetes
Alaeddine, L. M. (2022) · theses.fr (ABES) · doi:10.70675/41d9cd78zd5dez4ccfzae36zbb176db78e3f
Kashima, H., Kawai, M., Iimori, K., Nagao, M., Morikawa, T. J., Otomo, R., Hirai, M., Minaga, K., Asada, M., Umemura, A., et al. (2026) · Cancers · doi:10.3390/cancers18071177
“Eighth, diabetes mellitus is a known risk factor for pancreatic cancer [37–39].”
Diabetes mellitus and neoplastic diseases
Křivanová, A. (2026) · Onkologie · doi:10.36290/xon.2026.021
Liu, J. S., Wu, T., Xia, Q., & Zhang, S. (2026) · Archives of Medical Science · doi:10.5114/aoms/220327
“A registry study across five European countries, with a total of 9,149 cancers occurring among T1D patients in 3.9 million person-years, demonstrated 1.53-and 1.25-fold elevated risks of PCa among males and females, respectively [7].”
InfluentialAn 8-gene diabetes-related signature predicts survival and immunotherapy response in breast cancer
Jiang, X., Yin, J., Tong, Y., Li, J., Ren, X., & Zhu, C. (2026) · Clinics · doi:10.1016/j.clinsp.2026.100986
“25 26-29 Additionally, there are notable differences in the treatment options chosen for BRCA patients with and without diabetes.”
Prognosis of Type 1 Diabetes in Finland and its Determinants
Keisala, E. (2026) · Tampere University Institutional Repository (Tampere University)
Comment on: “lung cancer mortality among adults with diabetes: a retrospective analysis”
Ilyas, A. (2026) · Egyptian Journal of Bronchology · doi:10.1186/s43168-026-00625-0
“Moreover, smoking prevalence, healthcare utilization, and environmental exposures frequently differ across sex, racial, and geographic sub-groups, further complicating the interpretation of sub-group-specific mortality trends [9, 10].”
Balloura, M. A., Mawaldi, M., Johnson, B., Ovincy, C., Fontánez, N. C., Ingram, D., Me, H. M., Leeaphorn, N., & Attieh, R. M. (2026) · Clinical Transplantation · doi:10.1111/ctr.70621
“Although type 1 diabetes has been associated with a higher risk for certain cancers in prior studies [ 28– 30 ], this did not translate into a higher malignancy incidence among SPK recipients in our cohort.”
YiXie, Lin, Q., Guan, J., Li, J., Lin, Y., Wen, J., & Xu, B. (2026) · International Journal of Endocrinology · doi:10.1155/ije/2837214
Article title: The Link between Cancer, Autoimmunity and DiabetesPreprint
Petrić, D. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7322818
Juvenile Diabetes Mellitus is a Risk Factor of Different Types of Cancers: Systematic Review
Nawaf Farhan Alrawili, W. M. F., Falah, W. M., Alnujaydi, M. A. M., Alrumaih, Y. K. I., Alnujayd, A. A. M., & Alanazi, S. M. F. (2023) · Pakistan Heart Journal
Mishra, P., Pramodkumar, T. A., Pradhan, B., Ghosh, U., Mishra, P. K., Dash, P., Anjana, R. M., Patra, S. K., & Mohan, V. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01926-9
Сердечно-сосудистые заболевания и злокачественные новообразования — что общего?
Shlyk, I. F., Дмитриевна, К. В., & Besedina, D. Y. (2025) · Medical Herald of the South of Russia
Metadata
- Authors
- on behalf of the Diabetes and Cancer Research Consortium, Carstensen, B., Read, S. H., Friis, S., Sund, R., Keskimäki, I., Svensson, A.-M., Ljung, R., Wild, S. H., Kerssens, J. J., Harding, J. L., Magliano, D. J., & Gudbjörnsdottir, S.
- Affiliations
- University of Edinburgh (GB)
- Danish Cancer Society (DK)
- University of Helsinki (FI)
- Finnish Institute for Health and Welfare (FI)
- Karolinska Institutet (SE)
- National Health Service Scotland (GB)
- Baker Heart and Diabetes Institute (AU)
- Corresponding author
- Read, Stephanie H
- ORCID
- Venue
- Diabetologia
- Published
- 2016-02-29
- Volume
- 59
- Issue
- 5
- Pages
- 980-988
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC4826427
- OpenAlex
- W2288987572
- Cited by
- 180
- References
- 35
- Citations by year
- 2026: 17 · 2025: 14 · 2024: 27 · 2023: 18 · 2022: 28 · 2021: 20 · 2020: 17 · 2019: 12 · 2018: 8 · 2017: 12 · 2016: 6
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Tampere University Institutional Repository (Tampere University) (publishedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Tampere University Institutional Repository (Tampere University) (submittedVersion, cc-by)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- European Foundation for the Study of Diabetes
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- type 1 diabetes, cancer incidence, cancer risk, sex differences, gastric cancer, liver cancer, pancreatic cancer, endometrial cancer, kidney cancer, prostate cancer, site-specific cancer risk, diabetes registry, cancer registry, hazard ratio, age at cancer diagnosis, Australia, Denmark, Finland, Scotland, Sweden, United Kingdom
- MeSH terms
- Australia, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Finland, Humans, Male, Neoplasms, Risk Factors, Scotland, Sweden, Incidence, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.